About Central Venous Access Devices
Central venous access devices (CVADs) are catheters inserted into peripheral veins or central veins in the chest, neck or groin, which travel through the venous system so the distal tip is positioned in the lower third of the superior vena cava, cavoatrial junction, or the upper right atrium. It can also be used to measure blood flow (hemodynamic monitoring), to draw blood, or for other reasons. An increase in the acute CVC market is expected to apply upward pressure to the value of the total CVC market over the forecast period.
|Unit||Value (USD Million)|
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Manufacturers will contribute the maximum growth to Global Central Venous Access Devices market throughout the forecasted period. Established and emerging Manufacturers should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Becton, Dickinson and Company (United States), Cook Medical Inc (United States), Teleflex Inc (United States), C. R. Bard, Inc. (United States), Smith’s Medical, Inc. (United Kingdom), Boston Scientifi (United States), MEDICON, INC. (Japan), Teleflex Incorporated (United States), Kawasumi Laboratories, Inc. (Japan), Covidien Plc (Ireland), OrbusNeich Medical (Japan), Becton Dickinson (United States), Argon Medical Devices Japan K.K. (Japan) and Medical Components Inc (United States) are some of the key players that are part of study coverage.
AMA Research has segmented the market of Global Central Venous Access Devices market by Type (Peripherally Inserted Central Catheter (PICC), Non-Tunnelled Catheter (CVC), Tunnelled Central Venous Catheter (Hickman), Implanted Port (Port-A-Cath) and Others), Application (Medication Administration, Administration of Fluids Tand Nutritional Compounds, Transfusion of Blood Products and Diagnostic Testing) and Region.
On the basis of geography, the market of Central Venous Access Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Duration, the sub-segment i.e. Dwell time will boost the Central Venous Access Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Central Venous Access Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Technological Advancements in Vascular Access Devices and Shifts in Preference Towards Acute CVCs and Away from Chronic CVCs
Market Growth Drivers:
Increasing Number of Lumens and Catheter Diameter, Growing Use of Vascular Access Devices in Pediatric Patients and Increasing use of Antimicrobial CVCs for High-risk Patients
Risks Related to Vascular Access Devices
Alternate technologies and their current use in clinical practice
Increasing Focuses on Vascular Anastomosis Techniques and Arteriovenous Shunting and Innovation to Overcome the Shortcomings of Previous Technologies or Practices is an Ongoing Process By the Key Players
Market Leaders and their expansionary development strategies
On 6th Jan 2022, announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
Key Target AudienceBlood Transfusion Devices Manufacturers, Blood Transfusion Devices Distributors/Traders/Wholesalers, Blood Transfusion Devices Subcomponent Manufacturers, Industry Association, Medical Institutes, Government Regulatory Bodies, Government and Private Research Organizations and Others
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.